Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease.
Hufnagel K, Fathi A, Stroh N, Klein M, Skwirblies F, Girgis R, Dahlke C, Hoheisel JD, Lowy C, Schmidt R, Griesbeck A, Merle U, Addo MM, Schröder C.
Hufnagel K, et al. Among authors: lowy c.
Commun Med (Lond). 2023 Apr 12;3(1):51. doi: 10.1038/s43856-023-00283-z.
Commun Med (Lond). 2023.
PMID: 37041310
Free PMC article.